| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
NFKBIE |
NFKBIE, IKBE: NF-kappa-B inhibitor epsilon |
0.98 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
PAX5 |
PAX5: Paired box protein Pax-5 |
0.98 |
Evidence |
|
| CA6 |
CA6: Carbonic anhydrase 6 precursor |
SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
0.98 |
Evidence |
|
| FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.978 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.978 |
Evidence |
|
| FADD |
FADD, MORT1: Protein FADD |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.978 |
Evidence |
O
|
| CDH17 |
CDH17: Cadherin-17 precursor |
PKP3 |
PKP3: Plakophilin-3 |
0.978 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
ZAK |
MLTK, ZAK, HCCS4: Mitogen-activated protein kinase kinase kinase MLT |
0.978 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.978 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.978 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.978 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.978 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.978 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.978 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.978 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
DSG2 |
DSG2: Desmoglein-2 precursor |
0.978 |
Evidence |
|
| BMX |
IPI00514142 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.978 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.978 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.978 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.978 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.978 |
Evidence |
|
| MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
IL2 |
IL2: Interleukin 2 |
0.978 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CDH17 |
CDH17: Cadherin-17 precursor |
0.978 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
PKP3 |
PKP3: Plakophilin-3 |
0.978 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
FADD |
FADD, MORT1: Protein FADD |
0.978 |
Evidence |
|